Abramson Cancer Center University of Pennsylvania Philadelphia, Pennsylvania
In 1973, the University of Pennsylvania established a cancer center to serve as the focus and stimulus for all cancer-related activities at the University. In 1974, it was designated as a comprehensive cancer center by NCI and in 2002, it was renamed the Abramson Cancer Center of the University of Pennsylvania. The mission of the Center is the eradication of cancer as a cause of human disease and suffering. The Abramson Cancer Center seeks to achieve this through relentless progress in basic research, innovative translation of new knowledge through clinical trials, and state-of-the-art compassionate cancer care.
The 318 faculty members at the Center support 11 research programs that bring together investigators from 37 departments and eight schools with a shared interest in specific types of cancer or scientific themes. The goal of the Abramson Cancer Center is to facilitate collaborations that would otherwise not be possible in a traditional cancer center organized by departments. The research teams are multidisciplinary, bringing together experts in fundamental and translational research. The Center’s research programs cover: breast cancer, cancer control, cancer therapeutics, hematologic malignancies, immunobiology, melanoma and cutaneous malignancies, pediatric oncology, radiobiology and imaging, tobacco and environmental carcinogenesis, tumor biology, and tumor virology.
The Abramson Cancer Center established the Madlyn and Leonard Abramson Family Cancer Research Institute at the Center so that patients benefit directly from research advances. Additional institutions at the University of Pennsylvania related to the Center’s work are the Center for Cancer Pharmacology, the Center for Clinical Epidemiology and Biostatistics, the Center of Excellence in Cancer Communication Research, Leonard Davis Institute of Health Economics, the Center of Excellence in Environmental Toxicology, Center for Digestive, Liver, and Pancreatic Medicine, the Penn Genome Frontiers Institute, Institute for Translational Medicine and Therapeutics, and the Transdisciplinary Tobacco Use Research Center.
Cancer treatment at the Center is provided by multidisciplinary teams that include physician specialists, nurses, patient support specialists, cancer counselors, dietitians, and rehabilitation therapists. The full range of cancer therapies are offered at the Abramson Cancer Center’s main building, the Perelman Center for Advanced Medicine, including proton therapy at the Roberts Proton Therapy Center.
The Center makes a full range of clinical trials available to its cancer patients. It also provides assistance for cancer survivors through its Living Well After Cancer™ Program and LIVESTRONG Care Plan powered by Oncolink. A full range of support services are provided during and following treatment, from dietary plans to rehabilitation programs. The Center takes a holistic approach to care, addressing the psycho-social and physical needs of patients. The Abramson Cancer Center’s Penn Integrative Oncology Working Group, for example, offers support for patients who seek complementary or integrative medicine and wellness services to supplement traditional treatment services.
* This profile was provided by the Abramson Cancer Center.